Pro-epileptic effect of alfentanil in rats subjected to pilocarpine-induced chronic epilepsy

Brain Research Bulletin

Volumn 69, Issue 5, 2006, Pages 535-545

  Sanabria, Emilio Rafael Garrido ^b   D'Andrea Vieira, Isabella ^a   da Silveira Pereira, Maria Fernanda ^a   Faria, Leonardo Coutinho ^a   da Silva, André César ^a   Cavalheiro, Esper Abrão ^a   da Silva Fernandes, Maria José ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b The University of Brownsville at Texas   (United States)

Author keywords

Fentanyl; Hippocampus; Naloxone; Opioid; Seizures; Temporal lobe epilepsy

Indexed keywords

ALFENTANIL; MU OPIATE RECEPTOR; NALOXONE; PILOCARPINE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CONVULSION; DURA MATER; ELECTRODE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; SPIKE WAVE; TEMPORAL LOBE EPILEPSY;

ALFENTANIL; ANIMALS; BRAIN; CHRONIC DISEASE; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; EPILEPSY; ORGAN CULTURE TECHNIQUES; PILOCARPINE; RATS;

EID: 33646111919     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.02.016     Document Type: Article

References (76)

1. Akaishi T., Saito H., Ito Y., Ishige K., and Ikegaya Y. Morphine augments excitatory synaptic transmission in the dentate gyrus through GABAergic disinhibition. Neurosci Res 38 (2000) 357-363
2. Alarcon G., Garcia Seoane J.J., Binnie C.D., Martin Miguel M.C., Juler J., Polkey C.E., Elwes R.D., and Ortiz Blasco J.M. Origin and propagation of interictal discharges in the acute electrocorticogram. Implications for pathophysiology and surgical treatment of temporal lobe epilepsy. Brain 120 Pt 12 (1997) 2259-2282
3. Alojado M.E., Ohta Y., Yamamura T., and Kemmotsu O. The effect of fentanyl and morphine on neurons in the dorsal raphe nucleus in the rat: an in vitro study. Anesth. Analg. 78 (1994) 726-732
4. Baraka A., and Haroun S. Grand mal seizures following fentanyl-lidocaine. Anesthesiology 62 (1985) 206
5. Bausch S.B., and Chavkin C. Changes in hippocampal circuitry after pilocarpine-induced seizures as revealed by opioid receptor distribution and activation. J.Neurosci. 17 (1997) 477-492
6. Bell J.A., and Grant S.J. Locus coeruleus neurons from morphine-treated rats do not show opiate-withdrawal hyperactivity in vitro. Brain Res. 788 (1998) 237-244
7. Cain D.P., and Corcoran M.E. Epileptiform effects of met-enkephalin, beta-endorphin and morphine: kindling of generalized seizures and potentiation of epileptiform effects by handling. Brain Res. 338 (1985) 327-336
8. Capogna M., Gahwiler B.H., and Thompson S.M. Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. 470 (1993) 539-558
9. Cascino G.D., So E.L., Sharbrough F.W., Strelow D., Lagerlund T.D., Milde L.N., and O'Brien P.C. Alfentanil-induced epileptiform activity in patients with partial epilepsy. J. Clin. Neurophysiol. 10 (1993) 520-525
10. Cavalheiro E.A., Leite J.P., Bortolotto Z.A., Turski W.A., Ikonomidou C., and Turski L. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 32 (1991) 778-782
11. Chiu T.H., Yeh M.H., Tsai S.K., and Mok M.S. Electrophysiological actions of alfentanil: intracellular studies in the rat locus coeruleus neurones. Br. J. Pharmacol. 110 (1993) 903-909
12. Cox E.H., Kerbusch T., Van der Graaf P.H., and Danhof M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor. J. Pharmacol. Exp. Ther. 284 (1998) 1095-1103
13. Drake C.T., and Milner T.A. Mu opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippocampal formation. Brain Res. 849 (1999) 203-215
14. Drake C.T., and Milner T.A. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 12 (2002) 119-136
15. Ebling W.F., Lee E.N., and Stanski D.R. Understanding pharmacokinetics and pharmacodynamics through computer stimulation: I. The comparative clinical profiles of fentanyl and alfentanil. Anesthesiology 72 (1990) 650-658
16. Edwards S.R., Minto C.F., and Mather L.E. Concurrent ketamine and alfentanil administration: pharmacokinetic considerations. Br. J. Anaesth. 88 (2002) 94-100
17. Frost J.J., Mayberg H.S., Fisher R.S., Douglass K.H., Dannals R.F., Links J.M., Wilson A.A., Ravert H.T., Rosenbaum A.E., Snyder S.H., et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann. Neurol. 23 (1988) 231-237
18. Goroszeniuk T., Albin M., and Jones R.M. Generalized grand mal seizure after recovery from uncomplicated fentanyl-etomidate anesthesia. Anesth. Analg. 65 (1986) 979-981
19. Halasy K., Racz B., and Maderspach K. Kappa opioid receptors are expressed by interneurons in the CA1 area of the rat hippocampus: a correlated light and electron microscopic immunocytochemical study. J. Chem. Neuroanat. 19 (2000) 233-241
20. Heykants J., Geerts P., Noorduin H., and Vanden Bussche G. The pharmacokinetic basis of alfentanil infusion. Eur. J. Anaesthesiol. Suppl. 1 (1987) 17-24
21. Hoke J.F., Cunningham F., James M.K., Muir K.T., and Hoffman W.E. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J. Pharmacol. Exp. Ther. 281 (1997) 226-232
22. Jin W., and Chavkin C. Mu opioids enhance mossy fiber synaptic transmission indirectly by reducing GABAB receptor activation. Brain Res. 821 (1999) 286-293
23. Kalyuzhny A.E., and Wessendorf M.W. CNS GABA neurons express the mu-opioid receptor: immunocytochemical studies. Neuroreport 8 (1997) 3367-3372
24. Kalyuzhny A.E., and Wessendorf M.W. Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J. Comp. Neurol. 392 (1998) 528-547
25. Keene D.L., Roberts D., Splinter W.M., Higgins M., and Ventureyra E. Alfentanil mediated activation of epileptiform activity in the electrocorticogram during resection of epileptogenic foci. Can. J. Neurol. Sci. 24 (1997) 37-39
26. Kofke W.A., Garman R.H., Tom W.C., Rose M.E., and Hawkins R.A. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain. Anesth. Analg. 75 (1992) 953-964
27. Lambert N.A., Harrison N.L., and Teyler T.J. Evidence for mu opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neurosci Lett. 124 (1991) 101-104
28. Lee P.H., Obie J., and Hong J.S. Opioids induce convulsions and wet dog shakes in rats: mediation by hippocampal mu, but not delta or kappa opioid receptors. J. Neurosci. 9 (1989) 692-697
29. Lee P.H., Xie C.W., Lewis D.V., Wilson W.A., Mitchell C.L., and Hong J.S. Opioid-induced epileptiform bursting in hippocampal slices: higher susceptibility in ventral than dorsal hippocampus. J. Pharmacol. Exp. Ther. 253 (1990) 545-551
30. Leite J.P., Bortolotto Z.A., and Cavalheiro E.A. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci. Biobehav. Rev. 14 (1990) 511-517
31. Lemos T., and Cavalheiro E.A. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp. Brain Res. 102 (1995) 423-428
32. Lemos T., and Cavalheiro E.A. Status epilepticus and the late development of spontaneous seizures in the pilocarpine model of epilepsy. Epilepsy. Res. Suppl. 12 (1996) 137-144
33. Lupica C.R., and Dunwiddie T.V. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices. Synapse 8 (1991) 237-248
34. Manninen P.H., Burke S.J., Wennberg R., Lozano A.M., and El Beheiry H. Intraoperative localization of an epileptogenic focus with alfentanil and fentanyl. Anesth. Analg. 88 (1999) 1101-1106
35. Mansour A., and Valenstein E.S. Changes in responsiveness to mu and kappa opiates following a series of convulsions. Exp. Neurol. 90 (1985) 224-237
36. Matsumoto M., Collins J.G., Kitahata L.M., Yuge O., and Tanaka A. A comparison of the effects of alfentanil applied to the spinal cord and intravenous alfentanil on noxiously evoked activity of dorsal horn neurons in the cat spinal cord. Anesth. Analg. 65 (1986) 145-150
37. Mazarati A., Liu H., and Wasterlain C. Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus. Neuroscience 89 (1999) 167-173
38. McGuire G., El-Beheiry H., Manninen P., Lozano A., and Wennberg R. Activation of electrocorticographic activity with remifentanil and alfentanil during neurosurgical excision of epileptogenic focus. Br. J. Anaesth. 91 (2003) 651-655
39. McKhann II G.M., Schoenfeld-McNeill J., Born D.E., Haglund M.M., and Ojemann G.A. Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery. J. Neurosurg. 93 (2000) 44-52
40. Mello L.E., Cavalheiro E.A., Tan A.M., Kupfer W.R., Pretorius J.K., Babb T.L., and Finch D.M. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting. Epilepsia 34 (1993) 985-995
41. Mello L.E., Cavalheiro E.A., Tan A.M., Pretorius J.K., Babb T.L., and Finch D.M. Granule cell dispersion in relation to mossy fiber sprouting, hippocampal cell loss, silent period and seizure frequency in the pilocarpine model of epilepsy. Epilepsy. Res. Suppl. 9 (1992) 51-59 (Discussion 59-60)
42. Metz C., Gobel L., Gruber M., Hoerauf K.H., and Taeger K. Pharmacokinetics of human cerebral opioid extraction: a comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury. Anesthesiology 92 (2000) 1559-1567
43. Neumaier J.F., Mailheau S., and Chavkin C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. J. Pharmacol. Exp. Ther. 244 (1988) 564-570
44. Nicoll R.A., Alger B.E., and Jahr C.E. Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287 (1980) 22-25
45. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. fourth ed. (1998), Academic Press
46. Priel M.R., dos Santos N.F., and Cavalheiro E.A. Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res. 26 (1996) 115-121
47. Puig M.M., Miralles F., and Laorden L. Naloxone prevents hyperthermia induced convulsions in the immature rat. Methods Find Exp. Clin. Pharmacol. 8 (1986) 649-653
48. Ragazzo P.C., and Galanopoulou A.S. Alfentanil-induced activation: a promising tool in the presurgical evaluation of temporal lobe epilepsy patients. Brain Res. Brain Res. Rev. 32 (2000) 316-327
49. Rao T.L., Mummaneni N., and El-Etr A.A. Convulsions: an unusual response to intravenous fentanyl administration. Anesth. Analg. 61 (1982) 1020-1021
50. Ross J., Kearse Jr. L.A., Barlow M.K., Houghton K.J., and Cosgrove G.R. Alfentanil-induced epileptiform activity: a simultaneous surface and depth electroencephalographic study in complex partial epilepsy. Epilepsia 42 (2001) 220-225
51. Safwat A.M., and Daniel D. Grand mal seizure after fentanyl administration. Anesthesiology 59 (1983) 78
52. Sanabria E.R., Su H., and Yaari Y. Initiation of network bursts by Ca2+-dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy. J. Physiol. 532 (2001) 205-216
53. SanMartin S., Menendez L., Gutierrez M., Hidalgo A., and Baamonde A. Effects of DAGO on the rodent hippocampal evoked potentials using different perfusion solutions. Acta. Neurobiol. Exp. (Warsz) 60 (2000) 187-193
54. Scott J.C., Ponganis K.V., and Stanski D.R. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 62 (1985) 234-241
55. Siggins G.R., and Zieglgansberger W. Morphine and opioid peptides reduce inhibitory synaptic potentials in hippocampal pyramidal cells in vitro without alteration of membrane potential. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 5235-5239
56. Sinz E.H., Kofke W.A., and Garman R.H. Phenytoin, midazolam, and naloxone protect against fentanyl-induced brain damage in rats. Anesth. Analg. 91 (2000) 1443-1449
57. Skyers P.S., Einheber S., Pierce J.P., and Milner T.A. Increased mu-opioid receptor labeling is found on inner molecular layer terminals of the dentate gyrus following seizures. Exp. Neurol. 179 (2003) 200-209
58. Smith N.T., Benthuysen J.L., Bickford R.G., Sanford T.J., Blasco T., Duke P.C., Head N., and Dec-Silver H. Seizures during opioid anesthetic induction--are they opioid-induced rigidity?. Anesthesiology 71 (1989) 852-862
59. Stanski D.R. The clinical pharmacology of alfentanil. Eur. J. Anaesthesiol Suppl. 1 (1987) 3-11
60. Svensson A.I., Berntsson A., Eirefelt M., and Soderpalm B. Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes. J. Neural. Transm. 107 (2000) 261-270
61. Svoboda K.R., Adams C.E., and Lupica C.R. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J. Neurosci. 19 (1999) 85-95
62. Svoboda K.R., and Lupica C.R. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J. Neurosci. 18 (1998) 7084-7098
63. Swearengen E., and Chavkin C. NMDA receptor antagonist D-APV depresses excitatory activity produced by normorphine in rat hippocampal slices. Neurosci. Lett. 78 (1987) 80-84
64. Swearengen E., and Chavkin C. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology 28 (1989) 689-697
65. Sztriha L., Lelkes Z., Benedek G., and Joo F. Potentiating effect of morphine on seizures induced by kainic acid in rats. An electroencephalographic study. Naunyn Schmiedebergs Arch. Pharmacol. 333 (1986) 47-51
66. Tommasino C., Maekawa T., Shapiro H.M., Keifer-Goodman J., and Kohlenberger R.W. Fentanyl-induced seizures activate subcortical brain metabolism. Anesthesiology 60 (1984) 283-290
67. Tortella F.C., Robles L., and Mosberg H.I. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J. Pharmacol. Exp. Ther. 240 (1987) 571-577
68. Turski L., Cavalheiro E.A., Czuczwar S.J., Turski W.A., and Kleinrok Z. The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol. J. Pharmacol. Pharm. 39 (1987) 545-555
69. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9 (1983) 315-335
70. Upton R.N., Ludbrook G.L., Gray E.C., and Grant C. The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep. Anesthesiology 86 (1997) 1317-1325
71. Wass C.T., Grady R.E., Fessler A.J., Cascino G.D., Lozada L., Bechtle P.S., Marsh W.R., Sharbrough F.W., and Schroeder D.R. The effects of remifentanil on epileptiform discharges during intraoperative electrocorticography in patients undergoing epilepsy surgery. Epilepsia 42 (2001) 1340-1344
72. Wauquier A., De Ryck M., Van den Broeck W., Van Loon J., Melis W., and Janssen P. Relationships between quantitative EEG measures and pharmacodynamics of alfentanil in dogs. Electroencephalogr. Clin. Neurophysiol. 69 (1988) 550-560
73. Wiesner J.B., and Henriksen S.J. Enkephalin enhances responsiveness to perforant path input while decreasing spontaneous activity in the dentate gyrus. Neurosci. Lett. 74 (1987) 95-101
74. Zhao H., Xu H., and Xu X. Effects of naloxone on the long-term potentiation of EPSPs from the pathway of Schaffer collateral to CA1 region of hippocampus in aged rats with declined memory. Brain Res. 996 (2004) 111-116
75. Zieglgansberger W., French E.D., Siggins G.R., and Bloom F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205 (1979) 415-417
76. Zumsteg D., and Wieser H.G. Presurgical evaluation: current role of invasive EEG. Epilepsia 41 Suppl. 3 (2000) S55-S60